72% Pharma Sales Professionals have a fear of losing job due to COVID 19 pandemic..,

In a recently conducted online survey involving 2206 pharmaceutical sales professionals, it is found that 72% of them have a fear of losing job due to COVID 19 pandemic. In these days people assume that pharmaceutical and healthcare are the 2 industries which are growing due to pandemic and this survey observation is completely reverse.

K K Consulting Services, Mumbai recently conducted this survey involving pharmaceutical sales professionals from all over India. >50% participants of this survey have more than 10 years’ experience in pharmaceutical sales and around 59% of participants are presently working as team manager. Information received from such experienced professionals can’t be ignored.

Fear of losing job is observed slightly more among team managers than the medical representatives. Participants from East & North zone of India has observed with more fear of losing job (74%) than that of other 2 zones. West (71%), South (69%)

It is observed that participants feels that it will take around 0-6 month time to start doctors sales calls the normal way as it was happening before COVID pandemic.

To know more insight of this survey, connect K K Consulting Services, Mumbai at info@kkconsultingservices.com

Disclaimer

The opinions expressed in the survey do not reflect the opinions of KK Consulting Services or its Editors. Information contained in published results have been obtained from the survey. However, no author’s guarantees the accuracy or completeness of any information published herein and authors shall beresponsible for any errors, omissions, or claims for damages, arising out of use, inability to use, or with regard to the accuracy or sufficiency of the information contained in publications. No responsibility is assumed by the Publisher or Editors for any damage to persons or property as a matter of negligence, or otherwise, or from any use of informationby any methods, product, instructions, or ideas contained in the published material. Information in this publication is current as on date 6th July 2020.

All rights reserved. No part of any published work may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without written permission from the publisher.

Related Posts

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal, Ajinomoto team on ADC development and manufacturing

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Cancer cure must not be hostage to Big Pharma

Cancer cure must not be hostage to Big Pharma

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India